Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06652308
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-10-16
Brief Title:
Mood Disorders in Multiple Sclerosis Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Frequency of Unipolar and Bipolar Mood Disorders in Patients with Multiple Sclerosis a Retrospective Cohort Study
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MSMD
Brief Summary:
This study investigates the frequency of unipolar and bipolar mood disorders in patients with multiple sclerosis MS is a chronic condition that affects the central nervous system and previous research suggests that mood disorders such as depression and bipolar disorder may occur more frequently in MS patients compared to the general population
A retrospective analysis of 85 patients diagnosed with MS was conducted evaluating lifetime experiences with mood disorders using structured clinical interviews The goal is to better understand the prevalence of these mood disorders and to raise awareness of the importance of mental health care in patients with MS The findings highlight that mood disorders particularly bipolar disorder are more common in MS patients than previously thought This information can help healthcare providers improve screening diagnosis and treatment for MS patients suffering from mood disorders
A retrospective analysis of 85 patients diagnosed with MS was conducted evaluating lifetime experiences with mood disorders using structured clinical interviews The goal is to better understand the prevalence of these mood disorders and to raise awareness of the importance of mental health care in patients with MS The findings highlight that mood disorders particularly bipolar disorder are more common in MS patients than previously thought This information can help healthcare providers improve screening diagnosis and treatment for MS patients suffering from mood disorders
Detailed Description:
This study is a retrospective cohort analysis designed to examine the lifetime prevalence of unipolar and bipolar mood disorders in patients with multiple sclerosis MS is a chronic demyelinating condition of the central nervous system that leads to varying degrees of neurological impairment Previous studies have shown that mood disorders particularly depression and bipolar disorder are more prevalent in patients with MS than in the general population
Data from 85 patients 45 females and 40 males diagnosed with MS were analyzed focusing on psychiatric history through structured clinical interviews The study evaluated the presence of mood disorders including major depressive disorder bipolar disorder types I and II dysthymia and unclassified mood disorders Data were collected using DSM-IV criteria to ensure consistency in diagnosis
The results demonstrate that mood disorders especially bipolar disorder are more frequent than previously reported in this patient population These findings underscore the need for improved mental health screening and treatment for MS patients as managing psychiatric comorbidities can significantly enhance overall quality of life The study emphasizes the importance of integrating psychiatric care into routine MS management
Data from 85 patients 45 females and 40 males diagnosed with MS were analyzed focusing on psychiatric history through structured clinical interviews The study evaluated the presence of mood disorders including major depressive disorder bipolar disorder types I and II dysthymia and unclassified mood disorders Data were collected using DSM-IV criteria to ensure consistency in diagnosis
The results demonstrate that mood disorders especially bipolar disorder are more frequent than previously reported in this patient population These findings underscore the need for improved mental health screening and treatment for MS patients as managing psychiatric comorbidities can significantly enhance overall quality of life The study emphasizes the importance of integrating psychiatric care into routine MS management
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None